ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 332 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $26,200,652 | -7.4% | 993,578 | +6.7% | 0.02% | 0.0% |
| Q1 2024 | $28,285,403 | -1.1% | 931,360 | -8.6% | 0.02% | -9.5% |
| Q4 2023 | $28,613,204 | -19.2% | 1,018,626 | -21.9% | 0.02% | -27.6% |
| Q3 2023 | $35,411,159 | -11.8% | 1,304,759 | -0.1% | 0.03% | -6.5% |
| Q2 2023 | $40,143,028 | -13.5% | 1,305,889 | +1.4% | 0.03% | -11.4% |
| Q1 2023 | $46,400,515 | +16.5% | 1,287,830 | +27.7% | 0.04% | +9.4% |
| Q4 2022 | $39,842,602 | -1.6% | 1,008,163 | +0.0% | 0.03% | -3.0% |
| Q3 2022 | $40,494,000 | -4.1% | 1,007,820 | +0.4% | 0.03% | +3.1% |
| Q2 2022 | $42,218,000 | +17.7% | 1,004,234 | +9.1% | 0.03% | +33.3% |
| Q1 2022 | $35,870,000 | – | 920,681 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |